PharmiWeb.com - Global Pharma News & Resources
02-Apr-2019

Biofrontera AG: Biofrontera provides information on the announced voluntary public tender offer by Maruho Deutschland GmbH

DGAP-News: Biofrontera AG / Key word(s): Miscellaneous


The issuer is solely responsible for the content of this announcement.




02.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Germany
Phone: +49 (0)214 87632 0
Fax: +49 (0)214 87632 90
E-mail: ir@biofrontera.com
Internet: www.biofrontera.com
ISIN: DE0006046113, NASDAQ: BFRA
WKN: 604611
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Munich, Stuttgart, Tradegate Exchange; Nasdaq
EQS News ID: 794765

 
End of News DGAP News Service

Editor Details

Last Updated: 02-Apr-2019